Assessing Sionna Therapeutics (SION) Valuation After Recent Share Price Swings And Premium P/B Multiple [Yahoo! Finance]
Sionna Therapeutics, Inc. (SION)
Company Research
Source: Yahoo! Finance
See our latest analysis for Sionna Therapeutics. Looking beyond the latest move, Sionna Therapeutics has a 90 day share price return of 33.91% but a 30 day share price return of 8.23%. This suggests recent momentum has cooled after a stronger run earlier in the year. If Sionna has caught your eye and you want to see what else is out there in healthcare, this could be a good moment to browse healthcare stocks for more ideas. With Sionna Therapeutics still loss making, no revenue yet reported, and shares trading about 19% below the average analyst price target, you have to ask whether this is a genuine opening or if the market is already pricing in future growth. Sionna Therapeutics shares last closed at US$39.25, and the current valuation implies a P/B of 5.4x, which sits above the broader US Biotechs average. P/B compares the company's market value to its accounting book value. This can be a common yardstick for early stage or loss making biopharma names where earnings are
Show less
Read more
Impact Snapshot
Event Time:
SION
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SION alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SION alerts
High impacting Sionna Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SION
News
- Sionna Therapeutics (NASDAQ:SION) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $58.00 price target on the stock.MarketBeat
- Sionna Therapeutics (NASDAQ:SION) had its price target raised by analysts at BTIG Research from $50.00 to $58.00. They now have a "buy" rating on the stock.MarketBeat
- Sionna Therapeutics (NASDAQ:SION) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..MarketBeat
- Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- A Sionna Therapeutics (SION) Insider Sold 33,000 Shares for $1.5 Million [Yahoo! Finance]Yahoo! Finance
SION
Earnings
- 11/5/25 - Beat
SION
Sec Filings
- 1/6/26 - Form 4
- 1/6/26 - Form 4
- 1/6/26 - Form 4
- SION's page on the SEC website